Sharon Longhurst
Direktor/Vorstandsmitglied bei IDOGEN AB (PUBL)
Profil
Sharon Longhurst is currently an Independent Director at Idogen AB since 2020.
Prior to this, she worked as the Head of Chemistry, Manufacturing & Control at Mendus AB.
She also served as the Vice President of Development at Gadeta BV from 2021 to 2023.
Aktive Positionen von Sharon Longhurst
| Unternehmen | Position | Beginn |
|---|---|---|
| IDOGEN AB (PUBL) | Direktor/Vorstandsmitglied | 12.05.2020 |
| ELICERA THERAPEUTICS AB | Direktor/Vorstandsmitglied | 01.01.2024 |
Ehemalige bekannte Positionen von Sharon Longhurst
| Unternehmen | Position | Ende |
|---|---|---|
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Corporate Officer/Principal | 01.08.2023 |
| MENDUS AB | Corporate Officer/Principal | - |
Ausbildung von Sharon Longhurst
| University of Warwick | Doctorate Degree |
| University of Surrey | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IDOGEN AB (PUBL) | Health Technology |
| MENDUS AB | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
